https://www.openbell.ai/ 2026-09-24T12:39:25.851Z hourly 1.0 https://www.openbell.ai/support 2026-09-24T12:39:25.851Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-24T12:39:25.851Z monthly 0.5 https://www.openbell.ai/terms 2026-09-24T12:39:25.851Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-24T12:39:25.851Z hourly 0.8 https://www.openbell.ai/news/EPRX:1790253527261 2026-09-24T12:38:47.261Z daily 0.9 https://cdn.brandfetch.io/EPRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $17 Wedbush analyst Martin Fan has initiated coverage on Eupraxia Pharmaceuticals (NASDAQ: EPRX) with an Outperform rating. The firm has set a price target of $17 for the company's stock. https://www.openbell.ai/news/ORCL:1790253462893 2026-09-24T12:37:42.893Z daily 0.9 https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Oracle Cites ‘Force Majeure’ to Shield Itself on Controversial Data Center' - Bloomberg Oracle has invoked 'force majeure' in response to controversies surrounding its new data center project, which has faced significant opposition. The company's decision aims to protect itself from potential legal and financial repercussions related to the project. This move comes as Oracle continues to expand its cloud infrastructure amid growing scrutiny over its operational practices. https://www.openbell.ai/news/TRT:1790253352599 2026-09-24T12:35:52.599Z daily 0.9 https://cdn.brandfetch.io/TRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trio-Tech Intl Q4 EPS $0.02, Same YoY, Sales $14.931M Up From $10.671M YoY Trio-Tech Intl (NASDAQ: TRT) reported a quarterly earnings per share (EPS) of $0.02, which is unchanged from the same period last year. The company's sales for the quarter reached $14.931 million, reflecting a 39.92% increase compared to $10.671 million in the previous year. https://www.openbell.ai/news/VSTM:1790253305842 2026-09-24T12:35:05.842Z daily 0.9 https://cdn.brandfetch.io/VSTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Verastem Oncology Announces Presentation Of Phase 2 Biomarker Analysis For Avutometinib Plus Defactinib In Low-Grade Serous Ovarian Cancer openbell Financial News https://www.openbell.ai/news/GCTK:1790253288172 2026-09-24T12:34:48.172Z daily 0.9 https://cdn.brandfetch.io/GCTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud GlucoTrack shares are trading higher after the company announced its subsidiary, Lōkahi Therapeutics, engaged two ai PIPELINE project teams to identify and evaluate brain tumor therapeutic assets available for licensing and development. openbell Financial News https://www.openbell.ai/news/TAOP:1790253248408 2026-09-24T12:34:08.408Z daily 0.9 https://cdn.brandfetch.io/TAOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Taoping Awarded Multiple Smart Elevator Projects For Over $5.5M Taoping Inc. (Nasdaq: TAOP) announced that its subsidiary, Skyladder Technology, has been awarded multiple smart elevator projects with a total order value exceeding $5.5 million. This development highlights Taoping's ongoing expansion in the smart city and IoT sectors. https://www.openbell.ai/news/APUS:1790253203375 2026-09-24T12:33:23.375Z daily 0.9 https://cdn.brandfetch.io/APUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apimeds Pharmaceuticals' MindWave Signs 12-Month Contract To Build Conservation Credit Platform For AQUAE, Plus 20% Credit Allocation openbell Financial News https://www.openbell.ai/news/AMIX:1790253192069 2026-09-24T12:33:12.069Z daily 0.9 https://cdn.brandfetch.io/AMIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye Autonomix Medical, Inc. (NASDAQ: AMIX) has been granted European Patent No. EP 4 233 700 B1 for its technology titled 'Systems for Assessing Neural Activity in an Eye.' This patent enhances the company's intellectual property portfolio and provides additional protection for its technologies related to autonomic nervous system assessment and precision neuromodulation in Europe. https://www.openbell.ai/news/SPY:1790253135193 2026-09-24T12:32:15.193Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Initial Jobless Claims 197K Vs 201K Est. openbell Financial News https://www.openbell.ai/news/BTCUSD:1790253089484 2026-09-24T12:31:29.484Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Bitcoin-With-Golden-Stars.jpg?width=250&height=187 Bitcoin Broke Out While Gold, Stocks Struggled: It Feels Like 'The Upside Down' Crypto analyst Benjamin Cowen noted that Bitcoin (BTC) has broken out while other assets like gold and stocks are struggling, with the S&P 500 failing to reach new highs since mid-August. He highlighted rising oil prices and a 10-year yield at 5.1%, indicating that the Federal Reserve's current rate of 4% is insufficient to control inflation. Cowen observed that Bitcoin's recent performance, closing above its 50-week moving average, suggests bullish momentum, contrasting with the weakness seen in gold and silver. He emphasized that the next key indicator for Bitcoin will be its weekly close, with a drop below $83,000 potentially signaling a Q4 pullback. https://www.openbell.ai/news/MCD:1790253075270 2026-09-24T12:31:15.270Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $MCD Bearish sentiment surrounding McDonald's following a disappointing "Investor Day." Users express frustration and humor about potential losses tied to the stock. https://www.openbell.ai/news/BCML:1790253029291 2026-09-24T12:30:29.291Z daily 0.9 https://cdn.brandfetch.io/BCML/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Initiates Coverage On BayCom with Buy Rating, Announces Price Target of $35 StoneX analyst Andrew Liesch has initiated coverage on BayCom (NASDAQ: BCML) with a Buy rating. The analyst has set a price target of $35 for the stock. https://www.openbell.ai/news/P:1790252975197 2026-09-24T12:29:35.197Z daily 0.9 https://cdn.brandfetch.io/P/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Everpure, Raises Price Target to $145 Wells Fargo analyst Joe Quatrochi has maintained an Overweight rating on Everpure (NYSE: P) and raised the price target from $135 to $145. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/OKTA:1790252883736 2026-09-24T12:28:03.736Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Okta, Raises Price Target to $230 Wells Fargo analyst Richard Poland has maintained an Overweight rating on Okta (NASDAQ: OKTA) and raised the price target from $200 to $230. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/INFQ:1790252880365 2026-09-24T12:28:00.365Z daily 0.9 https://cdn.brandfetch.io/INFQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Infleqtion Announces It Has Achieved 30 Entangled Logical Qubits Using Just 80 Physical Qubits On Its Sqale Quantum Computing Platform Infleqtion (NYSE: INFQ) has achieved a significant milestone by successfully entangling 30 logical qubits using only 80 physical qubits on its Sqale quantum computing platform. This accomplishment marks Infleqtion as the first neutral-atom quantum computing company to reach this level on a commercial system, contributing to its roadmap goal of 100 logical qubits by 2028. The breakthrough was made possible through a combination of hardware and software co-design and AI-assisted discovery, which reduced the physical gates required for a key logical operation. https://www.openbell.ai/news/MGM:1790252820251 2026-09-24T12:27:00.251Z daily 0.9 https://cdn.brandfetch.io/MGM/w/400/h/400?c=1idopYfmtR7ZKg8QMud MGM Resorts International shares are trading lower after People announced it withdrew its proposal to purchase all public shares of the company. openbell Financial News https://www.openbell.ai/news/FRVO:1790252668148 2026-09-24T12:24:28.148Z daily 0.9 https://cdn.brandfetch.io/FRVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fervo Energy shares are trading higher after the company announced that Cape Station achieved First Power. openbell Financial News https://www.openbell.ai/news/ONB:1790252584493 2026-09-24T12:23:04.493Z daily 0.9 https://cdn.brandfetch.io/ONB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Initiates Coverage On Old National Bancorp with Overweight Rating, Announces Price Target of $30 Wells Fargo analyst Terry McEvoy has initiated coverage on Old National Bancorp (NASDAQ: ONB) with an Overweight rating. The firm has set a price target of $30 for the stock. https://www.openbell.ai/news/RVMD:1790252462891 2026-09-24T12:21:02.891Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Reinstates Buy on Revolution Medicines, Announces $267 Price Target Goldman Sachs analyst Andrea Newkirk has reinstated a Buy rating on Revolution Medicines (NASDAQ: RVMD) and set a price target of $267 for the stock. This strategic move indicates a positive outlook for the company's future performance. https://www.openbell.ai/news/ONON:1790252454627 2026-09-24T12:20:54.627Z daily 0.9 https://cdn.brandfetch.io/ONON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on On Holding, Raises Price Target to $44 Barclays analyst Adrienne Yih has maintained an Overweight rating on On Holding (NYSE: ONON) and raised the price target from $42 to $44. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/DBGI:1790252441943 2026-09-24T12:20:41.943Z daily 0.9 https://cdn.brandfetch.io/DBGI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Digital Brands Group’s AVO Reports 221% YoY Revenue Growth Between August 1 - September 11, 2026 Digital Brands Group, Inc. (NASDAQ: DBGI) reported a 221% year-over-year revenue growth for its collegiate licensing brand, AVO, from August 1 to September 11, 2026. During this period, AVO achieved a 3.65x return on ad spend while reducing digital marketing expenditures by 78%. Additionally, weekly net revenue increased by 442% among universities launched in 2026. AVO plans to launch a redesigned e-commerce platform in October to further enhance its performance metrics. https://www.openbell.ai/news/OKTA:1790252368770 2026-09-24T12:19:28.770Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Okta, Raises Price Target to $215 Barclays analyst Saket Kalia has maintained an Overweight rating on Okta (NASDAQ: OKTA) and increased the price target from $180 to $215. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/HAWK:1790252327127 2026-09-24T12:18:47.127Z daily 0.9 https://cdn.brandfetch.io/HAWK/w/400/h/400?c=1idopYfmtR7ZKg8QMud HawkEye 360 Announces Multiple Contract Awards In The Middle East Totaling ~$18M HawkEye 360 has secured multiple contract awards in the Middle East totaling approximately $18 million. These contracts focus on signals intelligence data, analytics, and mission support, enhancing the company's established relationships in the region. The awards highlight HawkEye 360's expanding presence and commitment to providing timely insights for defense and security organizations worldwide. https://www.openbell.ai/news/WTW:1790251909565 2026-09-24T12:11:49.565Z daily 0.9 https://cdn.brandfetch.io/WTW/w/400/h/400?c=1idopYfmtR7ZKg8QMud WTW Collaborates With Softtek Over AI Adoption For Organizations WTW (NASDAQ: WTW) has announced a strategic partnership with Softtek to enhance AI adoption for organizations. The collaboration aims to assist clients in aligning workforce strategy, organizational change, and technology implementation to achieve large-scale transformation, addressing challenges many face in operationalizing AI initiatives. https://www.openbell.ai/news/NWTG:1790251896724 2026-09-24T12:11:36.724Z daily 0.9 https://cdn.brandfetch.io/NWTG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Newton Golf Acquires Option on Nevada Beryllium-Tungsten Project; Amount Not Disclosed openbell Financial News https://www.openbell.ai/news/MOBX:1790251857571 2026-09-24T12:10:57.571Z daily 0.9 https://cdn.brandfetch.io/MOBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mobix Labs Expects Fiscal Q4 2026 Revenue Above $1.6M Guidance Midpoint, Up More Than 100% Sequentially openbell Financial News https://www.openbell.ai/news/IMNN:1790251839616 2026-09-24T12:10:39.616Z daily 0.9 https://cdn.brandfetch.io/IMNN/w/400/h/400?c=1idopYfmtR7ZKg8QMud IMUNON Reports Overall Survival Results, Advances Phase 3 OVATION 3 Trial IMUNON, Inc. (NASDAQ: IMNN) provided an update on its IMNN-001 development program for advanced ovarian cancer during its 2026 R&D Day. The presentation included final overall survival results from the Phase 2 OVATION 2 Study and preliminary findings from a minimal residual disease study conducted with Break Through Cancer. Additionally, the company highlighted progress in the ongoing Phase 3 OVATION 3 trial, which aims to confirm these findings. https://www.openbell.ai/news/SLB:1790251812775 2026-09-24T12:10:12.775Z daily 0.9 https://cdn.brandfetch.io/SLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud SLB Awarded Four Integrated Well Construction Contracts By Aramco For 450+ Wells Over Three Years, With Optional Extension Of Up To Two Years SLB has been awarded four integrated well construction contracts by Aramco, covering over 450 wells over a three-year period, with an option for a two-year extension. This expansion emphasizes the adoption of SLB's technology-enabled operating model, which integrates various aspects of well delivery to enhance efficiency and performance. The contracts signify a strengthening of the long-standing collaboration between SLB and Aramco in the oil and gas sector in Saudi Arabia. https://www.openbell.ai/news/NWTG:1790251811263 2026-09-24T12:10:11.263Z daily 0.9 https://cdn.brandfetch.io/NWTG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Newton Golf Acquires Option on Nevada Beryllium-Tungsten Project; Amount Not Disclosed openbell Financial News https://www.openbell.ai/news/LABT:1790251809555 2026-09-24T12:10:09.555Z daily 0.9 https://cdn.brandfetch.io/LABT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lakewood-Amedex Biotherapeutics Announces First Patient Dosed In Phase 2a Trial Of Nu-3 For Infected Diabetic Foot Ulcers; Topline Data Expected In Q1 2027 openbell Financial News https://www.openbell.ai/news/BETR:1790251771467 2026-09-24T12:09:31.467Z daily 0.9 https://cdn.brandfetch.io/BETR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Better Home & Finance Ex-CEO Vishal Garg Says Company Has Evidence Of Consents From More Than 46% Of Voting Power openbell Financial News https://www.openbell.ai/news/POM:1790251703495 2026-09-24T12:08:23.495Z daily 0.9 https://cdn.brandfetch.io/POM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pomdoctor Highlights Its Differentiated "Hardware + AI + Payment" Infrastructure Model Pomdoctor Limited (NASDAQ: POM) has emphasized its unique 'hardware + AI + payment' infrastructure model, which sets it apart from traditional internet healthcare platforms. The company aims to create a comprehensive digital healthcare technology infrastructure that integrates continuous health monitoring, AI analysis, physician intervention, and healthcare payment within a unified ecosystem, moving beyond the siloed services typically offered by competitors. https://www.openbell.ai/news/CWBC:1790251658746 2026-09-24T12:07:38.746Z daily 0.9 https://cdn.brandfetch.io/CWBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Initiates Coverage On Community West Bancshare with Buy Rating, Announces Price Target of $30 StoneX analyst Andrew Liesch has initiated coverage on Community West Bancshare (NASDAQ: CWBC) with a Buy rating. The firm has set a price target of $30 for the company's stock. https://www.openbell.ai/news/GSK:1790251646283 2026-09-24T12:07:26.283Z daily 0.9 https://cdn.brandfetch.io/GSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud GSK Says Health Canada Accepted Jemperli For Accelerated Review In Genetic Subtype Of Locally Advanced Rectal Cancer openbell Financial News https://www.openbell.ai/news/CLGN:1790251624354 2026-09-24T12:07:04.354Z daily 0.9 https://cdn.brandfetch.io/CLGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud CollPlant Announces Publication Of Joint Research Conducted By Its Subsidiary LightSolver Showing Photonic Computing Advantage Over GPUs CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) announced the publication of a peer-reviewed study by its subsidiary LightSolver, which demonstrates that LightSolver's Laser Processing Unit (LPU) architecture offers significantly lower projected time-to-solution compared to state-of-the-art GPU algorithms. This research was conducted in collaboration with the High-Performance Computing Center Stuttgart, highlighting the advantages of photonic computing over traditional computing methods. https://www.openbell.ai/news/LOW:1790251579332 2026-09-24T12:06:19.332Z daily 0.9 https://cdn.brandfetch.io/LOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lowe's Offers Drone Delivery Lowe's has initiated a pilot program for drone delivery in Charlotte, N.C., allowing customers to receive project essentials in as little as 20 minutes. The service enables customers to place orders through the DoorDash app, with deliveries conducted by Wing drones. https://www.openbell.ai/news/AUR:1790251578982 2026-09-24T12:06:18.982Z daily 0.9 https://cdn.brandfetch.io/AUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Canaccord Genuity Maintains Buy on Aurora Innovation, Raises Price Target to $17 Canaccord Genuity analyst George Gianarikas has maintained a Buy rating on Aurora Innovation (NASDAQ: AUR) and raised the price target from $15 to $17. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/NLST:1790251561939 2026-09-24T12:06:01.939Z daily 0.9 https://cdn.brandfetch.io/NLST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Netlist Says ITC Opens Patent Investigation Into Micron, Supermicro, HPE, And Lenovo Over Possible Import Ban On Micron Memory openbell Financial News https://www.openbell.ai/news/NVCT:1790251549156 2026-09-24T12:05:49.156Z daily 0.9 https://cdn.brandfetch.io/NVCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nuvectis Pharma's NXP200 BRAF Inhibitor Receives China's Breakthrough Therapy Designation Nuvectis Pharma, Inc. (NASDAQ: NVCT) announced that its oral BRAF inhibitor, NXP200 (HSK42360), has received Breakthrough Therapy Designation from China's Center for Drug Evaluation for treating patients with BRAF V600-mutant, recurrent or progressive high-grade glioma. This designation may expedite the development and review process for the drug in China. https://www.openbell.ai/news/DCX:1790251545102 2026-09-24T12:05:45.102Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, Digital Currency X (NASDAQ: DCX) saw a significant stock increase of 47.1% to $0.11, with a market value of $27.5 million. Other notable gainers included Springview Holdings (NASDAQ: SPHL), which rose by 21.22% to $2.8, and Uxin (NASDAQ: UXIN), which increased by 14.67% to $1.25 following its Q2 earnings report. Conversely, VisionSys AI (NASDAQ: VSA) experienced a decline of 25.0% to $2.73, while Stitch Fix (NASDAQ: SFIX) fell by 17.38% to $2.33 after its Q4 earnings report. https://www.openbell.ai/news/PFSA:1790251544894 2026-09-24T12:05:44.894Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, Profusa (NASDAQ: PFSA) saw a significant stock increase of 112.5% to $4.36, with a market cap of $1.2 million. GlucoTrack (NASDAQ: GCTK) also rose by 96.55% to $3.99, valuing its outstanding shares at $1.6 million. Conversely, Artelo Biosciences (NASDAQ: ARTL) experienced a decline of 30.1% to $5.11, bringing its market cap down to $4.0 million. Viking Therapeutics (NASDAQ: VKTX) fell by 12.25% to $36.55, with a market cap of $4.8 billion. https://www.openbell.ai/news/WETO:1790251544715 2026-09-24T12:05:44.715Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's Pre-Market Session During Thursday's pre-market session, Wetour Robotics (NASDAQ: WETO) saw a significant stock increase of 51.0%, reaching $2.19, with a market value of $1.5 million. Other notable gainers included Republic Airways Holdings (NASDAQ: RJET), which rose by 12.28% to $21.02, and Perpetuals.com (NASDAQ: PDC), up 12.0% to $4.48. Conversely, NeoVolta (NASDAQ: NEOV) experienced a sharp decline of 26.8%, falling to $2.32, following the release of its Q4 earnings. https://www.openbell.ai/news/AIMD:1790251543963 2026-09-24T12:05:43.963Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's Pre-Market Session During Thursday's pre-market session, several information technology stocks experienced notable movements. DNA X (SONM) saw a gain of 14.7% to $4.14, while Ainos (AIMD) rose by 13.35% to $1.58, with market caps of $5.3 million and $10.3 million respectively. Conversely, Alpha Technology Group (ATGL) faced a decline of 17.1% to $4.6, with a market cap of $91.3 million. Other significant losers included XIAO-I (AIXI) and BIO-key International (BKYI), which fell by 12.64% and 12.04% respectively. https://www.openbell.ai/news/MNTS:1790251498842 2026-09-24T12:04:58.842Z daily 0.9 https://cdn.brandfetch.io/MNTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Momentus Announces NASA Task Order Contract For Competitive Formulation Phase Of FALCON-Lidar Satellite Mission; Terms Not Disclosed openbell Financial News https://www.openbell.ai/news/HLIT:1790251489478 2026-09-24T12:04:49.478Z daily 0.9 https://cdn.brandfetch.io/HLIT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lightcurve Uses Harmonic's cOS To Deliver Multi-Gigabit Broadband Services To MDUs Over Coax Lightcurve has implemented Harmonic's cOS™ virtualized platform to provide multi-gigabit broadband services, delivering up to 8 Gbps downstream and 1 Gbps upstream to multi-dwelling units (MDUs) using existing coax infrastructure. This approach allows Lightcurve to offer competitive internet speeds without the expense of fiber overbuild, while also maintaining the option for future fiber integration. The virtualized access architecture supports these high speeds over DOCSIS technology. https://www.openbell.ai/news/SMBC:1790251460108 2026-09-24T12:04:20.108Z daily 0.9 https://cdn.brandfetch.io/SMBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Initiates Coverage On Southern Missouri Bancorp with Buy Rating, Announces Price Target of $80 StoneX analyst Andrew Liesch has initiated coverage on Southern Missouri Bancorp (NASDAQ: SMBC) with a Buy rating. The analyst has set a price target of $80 for the stock. https://www.openbell.ai/news/TVRD:1790251448685 2026-09-24T12:04:08.685Z daily 0.9 https://cdn.brandfetch.io/TVRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tvardi Therapeutics Announces Publication Of Preclinical Data Evaluating Its STAT3 Inhibitor In International Journal Of Molecular Sciences Tvardi Therapeutics, Inc. (NASDAQ: TVRD) announced the publication of preclinical data in the International Journal of Molecular Sciences, highlighting the efficacy of its STAT3 inhibitor, TTI-101, in a chronic colitis model. The data demonstrated that the oral small molecule achieved approximately 8-fold higher concentrations in the colon compared to plasma, effectively modulating disease biology associated with ulcerative colitis (UC). This publication supports the advancement of TTI-109, a next-generation STAT3 inhibitor, as a therapeutic approach for inflammatory bowel diseases, particularly given the elevated risk of colorectal cancer in UC patients. https://www.openbell.ai/news/TARS:1790251444011 2026-09-24T12:04:04.011Z daily 0.9 https://cdn.brandfetch.io/TARS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Reinstates Buy on Tarsus Pharmaceuticals, Announces $116 Price Target Goldman Sachs analyst Andrea Newkirk has reinstated a Buy rating on Tarsus Pharmaceuticals (NASDAQ: TARS) and set a price target of $116 for the stock. This strategic move indicates confidence in the company's future performance. https://www.openbell.ai/news/RVTY:1790251427856 2026-09-24T12:03:47.856Z daily 0.9 https://cdn.brandfetch.io/RVTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Revvity Rolls Out GSP T1D 3plex Kit Revvity, Inc. (NYSE: RVTY) has launched the GSP® T1D 3plex kit, a fully automated and CE-IVDR-certified solution for multiplex autoantibody detection. This kit is designed to facilitate population-wide screening programs aimed at identifying children at risk of developing type 1 diabetes (T1D) prior to the onset of symptoms. https://www.openbell.ai/news/MIST:1790251424732 2026-09-24T12:03:44.732Z daily 0.9 https://cdn.brandfetch.io/MIST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Milestone Pharmaceuticals Enrolls First Canadian Patient In Phase 3 Trial Of Etripamil For AFib With Rapid Heart Rate openbell Financial News